HEPATITIS A VIRUS: CORRELATION BETWEEN CLINICAL COURSE, BIOCHEMICAL FEATURES AND CELLULAR IMMUNE RESPONSES
Maria Bielawska, Zdzisław Dziubek, Janusz Cianciara
Institute of Infectious Diseases, Medical University of Warsaw, Poland
HEPATITIS E SEROCONVERSION IN HIV-INFECTED PATIENTS FROM WEST-CENTRAL POLAND – PRELIMINARY STUDY USING A NEW AUTOMATED TEST
Maciej Bura1, Aleksandra Bura2, Iwona Mozer-Lisewska1
1Klinika Chorób Zakaźnych, Hepatologii i Nabytych Niedoborów Odporności, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Polska
2Oddział Zakaźny, Wielospecjalistyczny Szpital Miejski im. Józefa Strusia z ZOL SP ZOZ, Poznań, Polska
AUTOIMMUNE LIVER DISEASES IN A CHILD WITH ULCERATIVE COLITIS. CASE PRESENTATION
Joanna Cielecka-Kuszyk1, Małgorzata Woźniak2, Bożena Cukrowska1, Joanna Pawłowska2
1Department of Pathology, Children’s Memorial Health Institute, Warsaw, Poland
2Department of Gastroenterology, Hepatology, Nutrition Disorders and Paediatrics, Children’s Memorial Health Institute, Warsaw, Poland
LONG-TERM OUTCOMES IN PATIENTS WITH COMPENSATED CIRRHOSIS DUE TO CHRONIC HEPATITIS C AFTER DIRECT ACTING ANTIVIRAL TREATMENT
Anna Dworzańska, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz
Department of Infectious Diseases, Medical University of Lublin, Poland
MULTI-PARAMETRIC MRI AS A COMPOSITE BIOMARKER FOR CLASSIFYING LIVER DISEASE IN PAEDIATRICS
Kamil Janowski1, Andrea Dennis2, Maciej Pronicki1, Wiesława Grajkowska1, Małgorzata Woźniak1, Piotr Pawliszak1, Elżbieta Jurkiewicz1, Rajarshi Banerjee2, Piotr Socha1
1Children’s Memorial Health Institute, Warsaw, Poland
2Perspectum Diagnostics, Oxford, United Kingdom
A COMBINED BLOOD AND MR IMAGING RISK SCORE FOR MONITORING LIVER INFLAMMATION IN PAEDIATRIC AIH
Kamil Janowski1, Andrea Dennis2, Maciej Pronicki1, Wiesława Grajkowska1, Małgorzata Woźniak1, Piotr Pawliszak1, Elżbieta Jurkiewicz1, Matt Kelly2, Stefan Neubauer2,3, Rajarshi Banerjee2, Piotr Socha1
1Children’s Memorial Health Institute, Warsaw, Polnad
2Perspectum Diagnostics, Oxford, United Kingdom
3University of Oxford, Oxford, United Kingdom
QUANTITATIVE MRCP IMAGING: PRELIMINARY OBSERVATIONS IN A COHORT OF PAEDIATRIC PATIENTS WITH LIVER AND BILIARY DISEASES
Kamil Janowski1, Gary Woodward2, Ged Ridgway2, Matt Kelly2, Velicia Bachtiar2, Maciej Pronicki1, Wiesława Grajkowska1, Małgorzata Woźniak1, Piotr Pawliszak1, Elżbieta Jurkiewicz1, Rajarshi Banerjee2, Piotr Socha1
1Children’s Memorial Health Institute, Warsaw, Poland
2Perspectum Diagnostics, Oxford, United Kingdom
PREVALENCE AND RISK FACTORS OF ANTI-HCV POSITIVITY AMONG PATIENTS WITH CARDIOVASCULAR DISEASES IN POLAND
Jerzy Jaroszewicz1, Monika Parys2, Daniel Cieśla2, Barbara Oczko-Grzesik1, Jacek Kaczmarski2, Mariusz Gąsior2,3
1Department of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, Poland
2Silesian Center for Heart Diseases, Zabrze, Poland
33rd Department of Cardiology, Medical University of Silesia in Katowice, Poland
LOW RISK OF HBV REACTIVATION IN A LARGE EUROPEAN COHORT OF HBV/HCV COINFECTED PATIENTS TREATED WITH DAA
Jerzy Jaroszewicz1, Maciej Piasecki1, Beata Lorenc2, Iwona Buczyńska3, Krzysztof Simon3, Dorota Zarębska-Michaluk4, Dorota Dybowska5, Waldemar Halota5, Małgorzata Pawłowska5, Aleksander Garlicki6, Teresa Belica-Wdowik7, Ewa Janczewska8, Beata Dobracka9, Magdalena Tudrujek-Zdunek10, Krzysztof Tomasiewicz10, Hanna Berak11, Włodzimierz Mazur12, Olga Tronina13, Jakub Klapaczyński14, Rafał Krygier15, Agnieszka Czauż-Andrzejuk16, Jolanta Citko17, Łukasz Socha18, Anna Piekarska19, Zbigniew Deroń20, Jolanta Białkowska21, Robert Flisiak16
1Department of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, Bytom, Poland
2Department of Infectious Diseases, Medical University of Gdańsk, Pomeranian Center of Infectious Diseases, Gdańsk, Poland
3Department of Infectious Diseases and Hepatology, Wrocław Medical University, Poland
4Department of Infectious Diseases, Voivodship Hospital and Jan Kochanowski University in Kielce, Poland
5Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland
6Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University in Kraków, Poland
7John Paul II Hospital, Regional Center for Diagnosis and Treatment of Viral Hepatitis and Hepatology, Kraków, Poland
8Department of Basic Medical Sciences, School of Public Health in Bytom, Medical University of Silesia; ID Clinic, Hepatology Outpatient Department, Bytom, Poland
9Medical Center, MEDFIX, Wrocław, Poland
10Department of Infectious Diseases, Medical University of Lublin, Poland
11Warsaw Medical University, Hospital for Infectious Diseases, Warsaw, Poland
12Clinical Department of Infectious Diseases, Specialist Hospital in Chorzów, Medical University of Silesia in Katowice, Poland
13Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Poland
14Central Clinical Hospital of Internal Affairs and Administration, Department of Internal Medicine and Hepatology, Warsaw, Poland
15Infectious Diseases and Hepatology Outpatient Clinic, NZOZ Gemini, Żychlin, Poland
16Department of Infectious Diseases and Hepatology, Medical University of Białystok, Poland
17Regional Hospital, Medical Practice of Infections, Olsztyn, Poland
18Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University in Szczecin, Poland
19Department of Infectious Diseases and Hepatology, Medical University of Łódź, Poland
20Ward of Infectious Diseases and Hepatology, Biegański Regional Specialist Hospital, Łódź, Poland
21Department of Infectious and Liver Diseases, Medical University of Łódź, Poland
LIVER FUNCTION IMPROVEMENT AFTER EFFECTIVE ANTIVIRAL TREATMENT IN CIRRHOTIC PATIENTS INFECTED WITH HEPATITIS C VIRUS
Paulina Klarczyńska1, Joanna Musialik2, Aleksander Owczarek3, Klaudia Adamczewska1, Katarzyna Szczepaniec1, Andrzej Więcek2
1School of Medicine in Katowice, Medical University of Silesia in Katowice, Poland
2School of Medicine in Katowice, Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia in Katowice, Poland
3School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Department of Statistics, Medical University of Silesia in Katowice, Poland
DESCRIPTION OF THE INNOVATIVE SOLUTION: “THE SYSTEM OF MAPPING OCCURRENCES OF ECHINOCOCCOSIS IN POLAND”
Natalia Kulawiak1, Marcin Kulawiak2, dr hab. n. med Katarzyna Sikorska1
1Klinika Chorób Tropikalnych, Uniwersyteckie Centrum Medycyny Morskiej i Tropikalnej w Gdyni, Polska
2Wydział Elektroniki, Telekomunikacji i Informatyki, Katedra Systemów Geoinformatycznych, Politechnika Gdańska, Polska
AGREEMENT BETWEEN CLINICAL DIAGNOSIS AND SELECTED METHODS FOR CAUSALITY ASSESSMENT IN DRUG-INDUCED LIVER INJURY
Dorota Latarska-Smuga, Aneta Cybula, Alicja Wiercińska-Drapało
Clinic of Infectious Diseases, Tropical Medicine and Hepatology, Warsaw Medical University, Poland
A TEN-YEAR RETROSPECTIVE ANALYSIS OF CAUSES AND CLINICAL FEATURES OF DRUG-INDUCED LIVER INJURY IN PATIENTS HOSPITALIZED IN THE CLINIC OF INFECTIOUS DISEASES, TROPICAL MEDICINE AND HEPATOLOGY IN WARSAW
Dorota Latarska-Smuga, Joanna Jabłońska, Tomasz Mikuła, Alicja Wiercińska-Drapało
Clinic of Infectious Diseases, Tropical Medicine and Hepatology, Warsaw Medical University, Poland
DRUG-INDUCED LIVER INJURY ASSOCIATED WITH AMOXYCILLIN/CLAVULANIC ACID – REVIEW OF 13 CLINICAL CASES
Dorota Latarska-Smuga, Magdalena Suchacz, Joanna Kozłowska, Alicja Wiercińska-Drapało
Clinic of Infectious Diseases, Tropical Medicine and Hepatology, Warsaw Medical University, Poland
FROM KIDNEY TO LIVER – UNUSUAL MANIFESTATION OF SYSTEMIC SARCOIDOSIS. CASE PRESENTATION
Agata Miśkiewicz1, Joanna Musialik1, Teresa Nieszporek1, Anna Kwaśniewska2, Henryk Karkoszka1, Maciej Kajor3, Andrzej Więcek1
1School of Medicine in Katowice, Department of Nephrology, Transplantation and Internal Diseases, Medical University of Silesia in Katowice, Poland
2Department of Radiology, The Mielecki Hospital, Medical University of Silesia in Katowice, Poland
3School of Medicine in Katowice, Department of Pathomorphology, Medical University of Silesia in Katowice, Poland
PHYTOTHERAPY IN HEPATO-ONCOLOGY
Paweł Słodnik, Christoph Zeller
Praxis am Bahnhof, Rueti, Switzerland
ACUTE HEPATITIS A IN CHILDREN – OWN OBSERVATIONS
Beata Smok1, Piotr Rabiko2, Małgorzata Sobolewska-Pilarczyk1, Małgorzata Pawłowska1
1Klinika Chorób Zakaźnych i Hepatologii, Collegium Medicum w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, Wydział Lekarski, Polska
2Wojewódzki Szpital Obserwacyjno-Zakaźny w Bydgoszczy, Poland
EFFICACY AND SAFETY OF HCV TREATMENT IN HEMODIALYZED PATIENTS – ANALYSIS OF EPITER-2 DATABASE
Krzysztof Tomasiewicz1, Robert Flisiak2, Beata Lorenc3, Olga Tronina4, Agnieszka Czauż-Andrzejuk2, Ewa Janczewska5, Jakub Klapaczynski6, Krzysztof Simon7, Beata Dobracka8, Aleksander Garlicki9, Dorota Zarębska-Michaluk10, Magdalena Tudrujek-Zdunek1, Jerzy Jaroszewicz11, Jolanta Citko12, Włodzimierz Mazur13, Dorota Dybowska14, Waldemar Halota14, Rafał Krygier15, Anna Piekarska16, Jolanta Białkowska17, Małgorzata Pawłowska14
1Department of Infectious Diseases, Medical University of Lublin, Poland
2Department of Infectious Diseases and Hepatology, Medical University of Białystok, Poland
3Pomeranian Center of Infectious Diseases, Department of Infectious Diseases, Medical University of Gdańsk, Poland
4Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Poland
5Department of Basic Medical Sciences in Bytom, Medical University of Silesia in Katowice, Poland
6Department of Internal Medicine and Hepatology, Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
7Department of Infectious Diseases and Hepatology, Wrocław Medical University, Poland
8Medical Center, MED-FIX, Wrocław, Poland
9Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University in Kraków, Poland
10Department of Infectious Diseases, Voivodship Hospital and Jan Kochanowski University in Kielce, Poland
11Department of Infectious Diseases in Bytom, Medical University of Silesia in Katowice, Poland
12Regional Hospital, Medical Practice of Infections, Olsztyn, Poland
13Clinical Department of Infectious Diseases in Chorzów, Medical University of Silesia in Katowice, Poland
14Department of Infectious Diseases and Hepatology, Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland
15Infectious Diseases and Hepatology Outpatient Clinic, NZOZ Gemini, Żychlin, Poland
16Department of Infectious Diseases and Hepatology, Medical University of Łódź, Poland
17Department of Infectious and Liver Diseases, Medical University of Łódź, Poland
PRIMARY HEALTH CARE (PHC) AS THE FIRST STEP IN IDENTIFICATION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS
Magdalena Tudrujek-Zdunek1, Agnieszka Kamińska2, Urszula Fałkowska2, Małgorzata Neścior2, Paulina Rudzka2, Aleksandra Majchrzak2, Krzysztof Tomasiewicz1
1Katedra i Klinika Chorób Zakaźnych, Uniwersytet Medyczny w Lublinie, Polska
2Studenckie Koło Naukowe przy Katedrze i Klinice Chorób Zakaźnych, Uniwersytet Medyczny w Lublinie, Polska
THE ROLE OF PRIMARY HEALTH CARE DOCTORS IN DIRECT ACTING ANTIVIRAL THERAPY OF HCV INFECTION – INTERVIEW SURVEY
Magdalena Tudrujek-Zdunek1, Aleksandra Majchrzak2, Aleksander Sławiński2, Jakub Latusek2, Krzysztof Tomasiewicz1
1Katedra i Klinika Chorób Zakaźnych, Uniwersytet Medyczny w Lublinie, Polska
2Studenckie Koło Naukowe przy Katedrze i Klinice Chorób Zakaźnych, Uniwersytet Medyczny w Lublinie, Polska
NEUTROCYTE TO LYMPHOCYTE RATIO PREDICTS THE PRESENCE OF A REPLICATIVE HEPATITIS C VIRUS STRAND AFTER THERAPY WITH DIRECTLY ACTING ANTIVIRALS
Anna Wróblewska1, Beata Lorenc2, Małgorzata Cheba2, Krzysztof P. Bielawski1, Katarzyna Sikorska3
1Laboratory of Molecular Diagnostics, Intercollegiate Faculty of Biotechnology UG & MUG, Gdańsk, Poland
2Pomeranian Center of Infectious Diseases and Tuberculosis, Gdańsk, Poland
3Department of Tropical Medicine and Epidemiology, Chair of Tropical Medicine and Parasitology, Institute of Maritime and Tropical Medicine, Faculty of Health Sciences, Medical University of Gdansk, Gdynia, Poland
REAL WORLD EXPERIENCE OF CHRONIC HEPATITIS C RETREATMENT WITH GENOTYPE SPECIFIC REGIMENS IN NON-RESPONDERS TO PREVIOUS INTERFERON-FREE THERAPY
Dorota Zarębska-Michaluk1, Iwona Buczyńska2, Krzysztof Simon2, Magdalena Tudrujek-Zdunek3, Ewa Janczewska4, Dorota Dybowska5, Marek Sitko6, Beata Dobracka7, Jerzy Jaroszewicz8, Paweł Pabjan1, Jakub Klapaczyński9, Łukasz Laurans10,11, Włodzimierz Mazur12, Łukasz Socha11, Olga Tronina13, Miłosz Parczewski14, Robert Flisiak15
1Department of Infectious Diseases, Voivodship Hospital and Jan Kochanowski University in Kielce, Poland
2Department of Infectious Diseases and Hepatology, Wrocław Medical University, Poland
3Department of Infectious Diseases and Hepatology, Medical University of Lublin, Poland
4Department of Basic Medical Sciences, School of Public Health in Bytom, Medical University of Silesia in Katowice, Poland
5Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland
6Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University in Kraków, Poland
7MED-FIX Medical Center, Wrocław, Poland
8Department of Infectious Diseases, Medical University of Silesia in Katowice, Bytom, Poland
9Department of Internal Medicine and Hepatology, Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
10Multidisciplinary Regional Hospital in Gorzów Wielkopolski, Gorzów Wielkopolski, Poland
11Department of Infectious Diseases, Hepatology, and Liver Transplantation, Pomeranian Medical University in Szczecin, Poland
12Clinical Department of Infectious Diseases, Specialist Hospital in Chorzów, Medical University of Silesia in Katowice, Poland
13Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Poland
14Department of Infectious, Tropical Diseases and Acquired Immunodeficiency, Pomeranian Medical University in Szczecin, Poland
15Department of Infectious Diseases and Hepatology, Medical University of Białystok, Poland
COMPARATIVE EFFECTIVENESS OF 8 VERSUS 12 WEEKS OF OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR IN TREATMENT-NAÏVE PATIENTS INFECTED WITH HCV GENOTYPE 1B WITH NON-ADVANCED HEPATIC FIBROSIS
Dorota Zarębska-Michaluk1, Jerzy Jaroszewicz2, Jakub Klapaczyński3, Włodzimierz Mazur4, Rafał Krygier5, Teresa Belica-Wdowik6, Barbara Baka-Ćwierz6, Ewa Janczewska7, Paweł Pabjan1, Beata Dobracka8, Beata Lorenc9, Magdalena Tudrujek-Zdunek10, Krzysztof Tomasiewicz10, Marek Sitko11, Aleksander Garlicki11, Agnieszka Czauż-Andrzejuk12, Jolanta Citko13, Dorota Dybowska14, Waldemar Halota14, Małgorzata Pawłowska14, Łukasz Laurans15, Zbigniew Deroń16, Iwona Buczyńska17, Krzysztof Simon17, Jolanta Białkowska18, Olga Tronina19, Robert Flisiak12
1Department of Infectious Diseases, Voivodeship Hospital and Jan Kochanowski University in Kielce, Poland
2Department of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, Bytom, Poland
3Department of Internal Medicine and Hepatology, Central Clinical Hospital of Internal Affairs and Administration, Warsaw, Poland
4Clinical Department of Infectious Diseases, Specialist Hospital in Chorzów, Medical University of Silesia in Katowice, Poland
5Infectious Diseases and Hepatology Outpatient Clinic, NZOZ Gemini, Żychlin, Poland
6John Paul II Hospital, Regional Center for Diagnosis and Treatment of Viral Hepatitis and Hepatology, Kraków, Poland
7Department of Basic Medical Sciences, Medical University of Silesia, School of Public Health in Bytom; ID Clinic, Hepatology Outpatient Department, Bytom, Poland
8Medical Center, MED-FIX, Wrocław, Poland
9Department of Infectious Diseases, Medical University of Gdańsk, Pomeranian Center of Infectious Diseases, Gdańsk, Poland
10Department of Infectious Diseases, Medical University of Lublin, Poland
11Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University in Kraków, Poland
12Department of Infectious Diseases and Hepatology, Medical University of Białystok, Poland
13Regional Hospital, Medical Practice of Infections, Olsztyn, Poland
14Department of Infectious Diseases and Hepatology, Faculty of Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland
15Outpatient Department, Multidisciplinary Regional Hospital, Gorzów Wielkopolski, Poland
16Ward of Infectious Diseases and Hepatology, Biegański Regional Specialist Hospital, Łódź, Poland
17Department of Infectious Diseases and Hepatology, Wroclaw University of Medicine, Poland
18Department of Infectious and Liver Diseases, Medical University of Łódź, Poland
19Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Poland
EFFICACY OF 8 VERSUS 12-WEEKS TREATMENT WITH LEDIPASVIR/SOFOSBUVIR IN CHRONIC HEPATITIS C PATIENTS ELIGIBLE FOR 8-WEEKS REGIMEN IN REAL WORLD SETTING
Dorota Zarębska-Michaluk1, Jerzy Jaroszewicz2, Jakub Klapaczyński3, Marek Sitko4, Aleksander Garlicki4, Magdalena Tudrujek-Zdunek5, Krzysztof Tomasiewicz5, Teresa Belica-Wdowik6, Barbara Baka-Ćwierz6, Paweł Pabjan1, Beata Lorenc7, Agnieszka Czauż-Andrzejuk8, Olga Tronina9, Rafał Krygier10, Beata Dobracka11, Iwona Buczyńska12, Krzysztof Simon12, Dorota Dybowska13, Waldemar Halota13, Małgorzata Pawłowska13, Jolanta Citko14, Łukasz Laurans15,19, Włodzimierz Mazur17, Anna Piekarska17, Ewa Janczewska18, Łukasz Socha19, Marta Wawrzynowicz-Syczewska19, Zbigniew Deroń20, Hanna Berak21, Andrzej Horban21, Robert Flisiak8
1Department of Infectious Diseases, Voivodeship Hospital and Jan Kochanowski University in Kielce, Poland
2Department of Infectious Diseases and Hepatology, Bytom, Medical University of Silesia in Katowice, Poland
3Department of Internal Medicine and Hepatology, Central Clinical Hospital of Internal Affairs and Administration, Warsaw, Poland
4Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University in Kraków, Poland
5Department of Infectious Diseases, Medical University of Lublin, Poland
6John Paul II Hospital, Regional Center for Diagnosis and Treatment of Viral Hepatitis and Hepatology, Kraków, Poland
7Department of Infectious Diseases, Medical University of Gdańsk, Pomeranian Center of Infectious Diseases, Gdańsk, Poland
8Department of Infectious Diseases and Hepatology, Medical University of Białystok, Poland
9Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Poland
10Infectious Diseases and Hepatology Outpatient Clinic, NZOZ Gemini, Żychlin, Poland
11Medical Center, MED-FIX, Wrocław, Poland
12Department of Infectious Diseases and Hepatology, Wroclaw University of Medicine, Poland
13Department of Infectious Diseases and Hepatology, Faculty of Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland
14Regional Hospital, Medical Practice of Infections, Olsztyn, Poland
15Multidisciplinary Regional Hospital, Outpatient Department, Gorzów Wielkopolski, Poland
16Clinical Department of Infectious Diseases, Specialist Hospital in Chorzów, Medical University of Silesia in Katowice, Poland
17Department of Infectious Diseases and Hepatology, Medical University of Łódź, Poland
18Department of Basic Medical Sciences, Medical University of Silesia, School of Public Health in Bytom; ID Clinic, Hepatology Outpatient Department, Bytom, Poland
19Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University in Szczecin, Poland
20Ward of Infectious Diseases and Hepatology, Biegański Regional Specialist Hospital, Łódź, Poland
21Warsaw Medical University, Hospital for Infectious Diseases, Warsaw, Poland
Maria Bielawska, Zdzisław Dziubek, Janusz Cianciara
Institute of Infectious Diseases, Medical University of Warsaw, Poland
HEPATITIS E SEROCONVERSION IN HIV-INFECTED PATIENTS FROM WEST-CENTRAL POLAND – PRELIMINARY STUDY USING A NEW AUTOMATED TEST
Maciej Bura1, Aleksandra Bura2, Iwona Mozer-Lisewska1
1Klinika Chorób Zakaźnych, Hepatologii i Nabytych Niedoborów Odporności, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Polska
2Oddział Zakaźny, Wielospecjalistyczny Szpital Miejski im. Józefa Strusia z ZOL SP ZOZ, Poznań, Polska
AUTOIMMUNE LIVER DISEASES IN A CHILD WITH ULCERATIVE COLITIS. CASE PRESENTATION
Joanna Cielecka-Kuszyk1, Małgorzata Woźniak2, Bożena Cukrowska1, Joanna Pawłowska2
1Department of Pathology, Children’s Memorial Health Institute, Warsaw, Poland
2Department of Gastroenterology, Hepatology, Nutrition Disorders and Paediatrics, Children’s Memorial Health Institute, Warsaw, Poland
LONG-TERM OUTCOMES IN PATIENTS WITH COMPENSATED CIRRHOSIS DUE TO CHRONIC HEPATITIS C AFTER DIRECT ACTING ANTIVIRAL TREATMENT
Anna Dworzańska, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz
Department of Infectious Diseases, Medical University of Lublin, Poland
MULTI-PARAMETRIC MRI AS A COMPOSITE BIOMARKER FOR CLASSIFYING LIVER DISEASE IN PAEDIATRICS
Kamil Janowski1, Andrea Dennis2, Maciej Pronicki1, Wiesława Grajkowska1, Małgorzata Woźniak1, Piotr Pawliszak1, Elżbieta Jurkiewicz1, Rajarshi Banerjee2, Piotr Socha1
1Children’s Memorial Health Institute, Warsaw, Poland
2Perspectum Diagnostics, Oxford, United Kingdom
A COMBINED BLOOD AND MR IMAGING RISK SCORE FOR MONITORING LIVER INFLAMMATION IN PAEDIATRIC AIH
Kamil Janowski1, Andrea Dennis2, Maciej Pronicki1, Wiesława Grajkowska1, Małgorzata Woźniak1, Piotr Pawliszak1, Elżbieta Jurkiewicz1, Matt Kelly2, Stefan Neubauer2,3, Rajarshi Banerjee2, Piotr Socha1
1Children’s Memorial Health Institute, Warsaw, Polnad
2Perspectum Diagnostics, Oxford, United Kingdom
3University of Oxford, Oxford, United Kingdom
QUANTITATIVE MRCP IMAGING: PRELIMINARY OBSERVATIONS IN A COHORT OF PAEDIATRIC PATIENTS WITH LIVER AND BILIARY DISEASES
Kamil Janowski1, Gary Woodward2, Ged Ridgway2, Matt Kelly2, Velicia Bachtiar2, Maciej Pronicki1, Wiesława Grajkowska1, Małgorzata Woźniak1, Piotr Pawliszak1, Elżbieta Jurkiewicz1, Rajarshi Banerjee2, Piotr Socha1
1Children’s Memorial Health Institute, Warsaw, Poland
2Perspectum Diagnostics, Oxford, United Kingdom
PREVALENCE AND RISK FACTORS OF ANTI-HCV POSITIVITY AMONG PATIENTS WITH CARDIOVASCULAR DISEASES IN POLAND
Jerzy Jaroszewicz1, Monika Parys2, Daniel Cieśla2, Barbara Oczko-Grzesik1, Jacek Kaczmarski2, Mariusz Gąsior2,3
1Department of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, Poland
2Silesian Center for Heart Diseases, Zabrze, Poland
33rd Department of Cardiology, Medical University of Silesia in Katowice, Poland
LOW RISK OF HBV REACTIVATION IN A LARGE EUROPEAN COHORT OF HBV/HCV COINFECTED PATIENTS TREATED WITH DAA
Jerzy Jaroszewicz1, Maciej Piasecki1, Beata Lorenc2, Iwona Buczyńska3, Krzysztof Simon3, Dorota Zarębska-Michaluk4, Dorota Dybowska5, Waldemar Halota5, Małgorzata Pawłowska5, Aleksander Garlicki6, Teresa Belica-Wdowik7, Ewa Janczewska8, Beata Dobracka9, Magdalena Tudrujek-Zdunek10, Krzysztof Tomasiewicz10, Hanna Berak11, Włodzimierz Mazur12, Olga Tronina13, Jakub Klapaczyński14, Rafał Krygier15, Agnieszka Czauż-Andrzejuk16, Jolanta Citko17, Łukasz Socha18, Anna Piekarska19, Zbigniew Deroń20, Jolanta Białkowska21, Robert Flisiak16
1Department of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, Bytom, Poland
2Department of Infectious Diseases, Medical University of Gdańsk, Pomeranian Center of Infectious Diseases, Gdańsk, Poland
3Department of Infectious Diseases and Hepatology, Wrocław Medical University, Poland
4Department of Infectious Diseases, Voivodship Hospital and Jan Kochanowski University in Kielce, Poland
5Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland
6Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University in Kraków, Poland
7John Paul II Hospital, Regional Center for Diagnosis and Treatment of Viral Hepatitis and Hepatology, Kraków, Poland
8Department of Basic Medical Sciences, School of Public Health in Bytom, Medical University of Silesia; ID Clinic, Hepatology Outpatient Department, Bytom, Poland
9Medical Center, MEDFIX, Wrocław, Poland
10Department of Infectious Diseases, Medical University of Lublin, Poland
11Warsaw Medical University, Hospital for Infectious Diseases, Warsaw, Poland
12Clinical Department of Infectious Diseases, Specialist Hospital in Chorzów, Medical University of Silesia in Katowice, Poland
13Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Poland
14Central Clinical Hospital of Internal Affairs and Administration, Department of Internal Medicine and Hepatology, Warsaw, Poland
15Infectious Diseases and Hepatology Outpatient Clinic, NZOZ Gemini, Żychlin, Poland
16Department of Infectious Diseases and Hepatology, Medical University of Białystok, Poland
17Regional Hospital, Medical Practice of Infections, Olsztyn, Poland
18Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University in Szczecin, Poland
19Department of Infectious Diseases and Hepatology, Medical University of Łódź, Poland
20Ward of Infectious Diseases and Hepatology, Biegański Regional Specialist Hospital, Łódź, Poland
21Department of Infectious and Liver Diseases, Medical University of Łódź, Poland
LIVER FUNCTION IMPROVEMENT AFTER EFFECTIVE ANTIVIRAL TREATMENT IN CIRRHOTIC PATIENTS INFECTED WITH HEPATITIS C VIRUS
Paulina Klarczyńska1, Joanna Musialik2, Aleksander Owczarek3, Klaudia Adamczewska1, Katarzyna Szczepaniec1, Andrzej Więcek2
1School of Medicine in Katowice, Medical University of Silesia in Katowice, Poland
2School of Medicine in Katowice, Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia in Katowice, Poland
3School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Department of Statistics, Medical University of Silesia in Katowice, Poland
DESCRIPTION OF THE INNOVATIVE SOLUTION: “THE SYSTEM OF MAPPING OCCURRENCES OF ECHINOCOCCOSIS IN POLAND”
Natalia Kulawiak1, Marcin Kulawiak2, dr hab. n. med Katarzyna Sikorska1
1Klinika Chorób Tropikalnych, Uniwersyteckie Centrum Medycyny Morskiej i Tropikalnej w Gdyni, Polska
2Wydział Elektroniki, Telekomunikacji i Informatyki, Katedra Systemów Geoinformatycznych, Politechnika Gdańska, Polska
AGREEMENT BETWEEN CLINICAL DIAGNOSIS AND SELECTED METHODS FOR CAUSALITY ASSESSMENT IN DRUG-INDUCED LIVER INJURY
Dorota Latarska-Smuga, Aneta Cybula, Alicja Wiercińska-Drapało
Clinic of Infectious Diseases, Tropical Medicine and Hepatology, Warsaw Medical University, Poland
A TEN-YEAR RETROSPECTIVE ANALYSIS OF CAUSES AND CLINICAL FEATURES OF DRUG-INDUCED LIVER INJURY IN PATIENTS HOSPITALIZED IN THE CLINIC OF INFECTIOUS DISEASES, TROPICAL MEDICINE AND HEPATOLOGY IN WARSAW
Dorota Latarska-Smuga, Joanna Jabłońska, Tomasz Mikuła, Alicja Wiercińska-Drapało
Clinic of Infectious Diseases, Tropical Medicine and Hepatology, Warsaw Medical University, Poland
DRUG-INDUCED LIVER INJURY ASSOCIATED WITH AMOXYCILLIN/CLAVULANIC ACID – REVIEW OF 13 CLINICAL CASES
Dorota Latarska-Smuga, Magdalena Suchacz, Joanna Kozłowska, Alicja Wiercińska-Drapało
Clinic of Infectious Diseases, Tropical Medicine and Hepatology, Warsaw Medical University, Poland
FROM KIDNEY TO LIVER – UNUSUAL MANIFESTATION OF SYSTEMIC SARCOIDOSIS. CASE PRESENTATION
Agata Miśkiewicz1, Joanna Musialik1, Teresa Nieszporek1, Anna Kwaśniewska2, Henryk Karkoszka1, Maciej Kajor3, Andrzej Więcek1
1School of Medicine in Katowice, Department of Nephrology, Transplantation and Internal Diseases, Medical University of Silesia in Katowice, Poland
2Department of Radiology, The Mielecki Hospital, Medical University of Silesia in Katowice, Poland
3School of Medicine in Katowice, Department of Pathomorphology, Medical University of Silesia in Katowice, Poland
PHYTOTHERAPY IN HEPATO-ONCOLOGY
Paweł Słodnik, Christoph Zeller
Praxis am Bahnhof, Rueti, Switzerland
ACUTE HEPATITIS A IN CHILDREN – OWN OBSERVATIONS
Beata Smok1, Piotr Rabiko2, Małgorzata Sobolewska-Pilarczyk1, Małgorzata Pawłowska1
1Klinika Chorób Zakaźnych i Hepatologii, Collegium Medicum w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, Wydział Lekarski, Polska
2Wojewódzki Szpital Obserwacyjno-Zakaźny w Bydgoszczy, Poland
EFFICACY AND SAFETY OF HCV TREATMENT IN HEMODIALYZED PATIENTS – ANALYSIS OF EPITER-2 DATABASE
Krzysztof Tomasiewicz1, Robert Flisiak2, Beata Lorenc3, Olga Tronina4, Agnieszka Czauż-Andrzejuk2, Ewa Janczewska5, Jakub Klapaczynski6, Krzysztof Simon7, Beata Dobracka8, Aleksander Garlicki9, Dorota Zarębska-Michaluk10, Magdalena Tudrujek-Zdunek1, Jerzy Jaroszewicz11, Jolanta Citko12, Włodzimierz Mazur13, Dorota Dybowska14, Waldemar Halota14, Rafał Krygier15, Anna Piekarska16, Jolanta Białkowska17, Małgorzata Pawłowska14
1Department of Infectious Diseases, Medical University of Lublin, Poland
2Department of Infectious Diseases and Hepatology, Medical University of Białystok, Poland
3Pomeranian Center of Infectious Diseases, Department of Infectious Diseases, Medical University of Gdańsk, Poland
4Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Poland
5Department of Basic Medical Sciences in Bytom, Medical University of Silesia in Katowice, Poland
6Department of Internal Medicine and Hepatology, Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
7Department of Infectious Diseases and Hepatology, Wrocław Medical University, Poland
8Medical Center, MED-FIX, Wrocław, Poland
9Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University in Kraków, Poland
10Department of Infectious Diseases, Voivodship Hospital and Jan Kochanowski University in Kielce, Poland
11Department of Infectious Diseases in Bytom, Medical University of Silesia in Katowice, Poland
12Regional Hospital, Medical Practice of Infections, Olsztyn, Poland
13Clinical Department of Infectious Diseases in Chorzów, Medical University of Silesia in Katowice, Poland
14Department of Infectious Diseases and Hepatology, Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland
15Infectious Diseases and Hepatology Outpatient Clinic, NZOZ Gemini, Żychlin, Poland
16Department of Infectious Diseases and Hepatology, Medical University of Łódź, Poland
17Department of Infectious and Liver Diseases, Medical University of Łódź, Poland
PRIMARY HEALTH CARE (PHC) AS THE FIRST STEP IN IDENTIFICATION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS
Magdalena Tudrujek-Zdunek1, Agnieszka Kamińska2, Urszula Fałkowska2, Małgorzata Neścior2, Paulina Rudzka2, Aleksandra Majchrzak2, Krzysztof Tomasiewicz1
1Katedra i Klinika Chorób Zakaźnych, Uniwersytet Medyczny w Lublinie, Polska
2Studenckie Koło Naukowe przy Katedrze i Klinice Chorób Zakaźnych, Uniwersytet Medyczny w Lublinie, Polska
THE ROLE OF PRIMARY HEALTH CARE DOCTORS IN DIRECT ACTING ANTIVIRAL THERAPY OF HCV INFECTION – INTERVIEW SURVEY
Magdalena Tudrujek-Zdunek1, Aleksandra Majchrzak2, Aleksander Sławiński2, Jakub Latusek2, Krzysztof Tomasiewicz1
1Katedra i Klinika Chorób Zakaźnych, Uniwersytet Medyczny w Lublinie, Polska
2Studenckie Koło Naukowe przy Katedrze i Klinice Chorób Zakaźnych, Uniwersytet Medyczny w Lublinie, Polska
NEUTROCYTE TO LYMPHOCYTE RATIO PREDICTS THE PRESENCE OF A REPLICATIVE HEPATITIS C VIRUS STRAND AFTER THERAPY WITH DIRECTLY ACTING ANTIVIRALS
Anna Wróblewska1, Beata Lorenc2, Małgorzata Cheba2, Krzysztof P. Bielawski1, Katarzyna Sikorska3
1Laboratory of Molecular Diagnostics, Intercollegiate Faculty of Biotechnology UG & MUG, Gdańsk, Poland
2Pomeranian Center of Infectious Diseases and Tuberculosis, Gdańsk, Poland
3Department of Tropical Medicine and Epidemiology, Chair of Tropical Medicine and Parasitology, Institute of Maritime and Tropical Medicine, Faculty of Health Sciences, Medical University of Gdansk, Gdynia, Poland
REAL WORLD EXPERIENCE OF CHRONIC HEPATITIS C RETREATMENT WITH GENOTYPE SPECIFIC REGIMENS IN NON-RESPONDERS TO PREVIOUS INTERFERON-FREE THERAPY
Dorota Zarębska-Michaluk1, Iwona Buczyńska2, Krzysztof Simon2, Magdalena Tudrujek-Zdunek3, Ewa Janczewska4, Dorota Dybowska5, Marek Sitko6, Beata Dobracka7, Jerzy Jaroszewicz8, Paweł Pabjan1, Jakub Klapaczyński9, Łukasz Laurans10,11, Włodzimierz Mazur12, Łukasz Socha11, Olga Tronina13, Miłosz Parczewski14, Robert Flisiak15
1Department of Infectious Diseases, Voivodship Hospital and Jan Kochanowski University in Kielce, Poland
2Department of Infectious Diseases and Hepatology, Wrocław Medical University, Poland
3Department of Infectious Diseases and Hepatology, Medical University of Lublin, Poland
4Department of Basic Medical Sciences, School of Public Health in Bytom, Medical University of Silesia in Katowice, Poland
5Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland
6Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University in Kraków, Poland
7MED-FIX Medical Center, Wrocław, Poland
8Department of Infectious Diseases, Medical University of Silesia in Katowice, Bytom, Poland
9Department of Internal Medicine and Hepatology, Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
10Multidisciplinary Regional Hospital in Gorzów Wielkopolski, Gorzów Wielkopolski, Poland
11Department of Infectious Diseases, Hepatology, and Liver Transplantation, Pomeranian Medical University in Szczecin, Poland
12Clinical Department of Infectious Diseases, Specialist Hospital in Chorzów, Medical University of Silesia in Katowice, Poland
13Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Poland
14Department of Infectious, Tropical Diseases and Acquired Immunodeficiency, Pomeranian Medical University in Szczecin, Poland
15Department of Infectious Diseases and Hepatology, Medical University of Białystok, Poland
COMPARATIVE EFFECTIVENESS OF 8 VERSUS 12 WEEKS OF OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR IN TREATMENT-NAÏVE PATIENTS INFECTED WITH HCV GENOTYPE 1B WITH NON-ADVANCED HEPATIC FIBROSIS
Dorota Zarębska-Michaluk1, Jerzy Jaroszewicz2, Jakub Klapaczyński3, Włodzimierz Mazur4, Rafał Krygier5, Teresa Belica-Wdowik6, Barbara Baka-Ćwierz6, Ewa Janczewska7, Paweł Pabjan1, Beata Dobracka8, Beata Lorenc9, Magdalena Tudrujek-Zdunek10, Krzysztof Tomasiewicz10, Marek Sitko11, Aleksander Garlicki11, Agnieszka Czauż-Andrzejuk12, Jolanta Citko13, Dorota Dybowska14, Waldemar Halota14, Małgorzata Pawłowska14, Łukasz Laurans15, Zbigniew Deroń16, Iwona Buczyńska17, Krzysztof Simon17, Jolanta Białkowska18, Olga Tronina19, Robert Flisiak12
1Department of Infectious Diseases, Voivodeship Hospital and Jan Kochanowski University in Kielce, Poland
2Department of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, Bytom, Poland
3Department of Internal Medicine and Hepatology, Central Clinical Hospital of Internal Affairs and Administration, Warsaw, Poland
4Clinical Department of Infectious Diseases, Specialist Hospital in Chorzów, Medical University of Silesia in Katowice, Poland
5Infectious Diseases and Hepatology Outpatient Clinic, NZOZ Gemini, Żychlin, Poland
6John Paul II Hospital, Regional Center for Diagnosis and Treatment of Viral Hepatitis and Hepatology, Kraków, Poland
7Department of Basic Medical Sciences, Medical University of Silesia, School of Public Health in Bytom; ID Clinic, Hepatology Outpatient Department, Bytom, Poland
8Medical Center, MED-FIX, Wrocław, Poland
9Department of Infectious Diseases, Medical University of Gdańsk, Pomeranian Center of Infectious Diseases, Gdańsk, Poland
10Department of Infectious Diseases, Medical University of Lublin, Poland
11Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University in Kraków, Poland
12Department of Infectious Diseases and Hepatology, Medical University of Białystok, Poland
13Regional Hospital, Medical Practice of Infections, Olsztyn, Poland
14Department of Infectious Diseases and Hepatology, Faculty of Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland
15Outpatient Department, Multidisciplinary Regional Hospital, Gorzów Wielkopolski, Poland
16Ward of Infectious Diseases and Hepatology, Biegański Regional Specialist Hospital, Łódź, Poland
17Department of Infectious Diseases and Hepatology, Wroclaw University of Medicine, Poland
18Department of Infectious and Liver Diseases, Medical University of Łódź, Poland
19Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Poland
EFFICACY OF 8 VERSUS 12-WEEKS TREATMENT WITH LEDIPASVIR/SOFOSBUVIR IN CHRONIC HEPATITIS C PATIENTS ELIGIBLE FOR 8-WEEKS REGIMEN IN REAL WORLD SETTING
Dorota Zarębska-Michaluk1, Jerzy Jaroszewicz2, Jakub Klapaczyński3, Marek Sitko4, Aleksander Garlicki4, Magdalena Tudrujek-Zdunek5, Krzysztof Tomasiewicz5, Teresa Belica-Wdowik6, Barbara Baka-Ćwierz6, Paweł Pabjan1, Beata Lorenc7, Agnieszka Czauż-Andrzejuk8, Olga Tronina9, Rafał Krygier10, Beata Dobracka11, Iwona Buczyńska12, Krzysztof Simon12, Dorota Dybowska13, Waldemar Halota13, Małgorzata Pawłowska13, Jolanta Citko14, Łukasz Laurans15,19, Włodzimierz Mazur17, Anna Piekarska17, Ewa Janczewska18, Łukasz Socha19, Marta Wawrzynowicz-Syczewska19, Zbigniew Deroń20, Hanna Berak21, Andrzej Horban21, Robert Flisiak8
1Department of Infectious Diseases, Voivodeship Hospital and Jan Kochanowski University in Kielce, Poland
2Department of Infectious Diseases and Hepatology, Bytom, Medical University of Silesia in Katowice, Poland
3Department of Internal Medicine and Hepatology, Central Clinical Hospital of Internal Affairs and Administration, Warsaw, Poland
4Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University in Kraków, Poland
5Department of Infectious Diseases, Medical University of Lublin, Poland
6John Paul II Hospital, Regional Center for Diagnosis and Treatment of Viral Hepatitis and Hepatology, Kraków, Poland
7Department of Infectious Diseases, Medical University of Gdańsk, Pomeranian Center of Infectious Diseases, Gdańsk, Poland
8Department of Infectious Diseases and Hepatology, Medical University of Białystok, Poland
9Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Poland
10Infectious Diseases and Hepatology Outpatient Clinic, NZOZ Gemini, Żychlin, Poland
11Medical Center, MED-FIX, Wrocław, Poland
12Department of Infectious Diseases and Hepatology, Wroclaw University of Medicine, Poland
13Department of Infectious Diseases and Hepatology, Faculty of Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland
14Regional Hospital, Medical Practice of Infections, Olsztyn, Poland
15Multidisciplinary Regional Hospital, Outpatient Department, Gorzów Wielkopolski, Poland
16Clinical Department of Infectious Diseases, Specialist Hospital in Chorzów, Medical University of Silesia in Katowice, Poland
17Department of Infectious Diseases and Hepatology, Medical University of Łódź, Poland
18Department of Basic Medical Sciences, Medical University of Silesia, School of Public Health in Bytom; ID Clinic, Hepatology Outpatient Department, Bytom, Poland
19Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University in Szczecin, Poland
20Ward of Infectious Diseases and Hepatology, Biegański Regional Specialist Hospital, Łódź, Poland
21Warsaw Medical University, Hospital for Infectious Diseases, Warsaw, Poland